Gain Therapeutics (GANX.US) Financial Statements - Balance Sheet/Income Statement/Cash Flow

Event Tracking

Nov15

BTIG Maintains Buy Rating on Gain Therapeutics

17:32

Nov13

Gain Therapeutics released FY2025 9 Months Earnings on November 12 (EST), with actual revenue of USD 0 and EPS of USD -0.5003

04:00

Gain Therapeutics released FY2025 Q3 earnings on November 12 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -0.1509 (forecast USD -0.165)

04:00

Oct17

Ram Selvaraju Maintains Buy Rating on Gain Therapeutics

10:31

Oct14

Gain Therapeutics Discusses Latest Advancements of Parkinson's Drug GT-02287

21:06

Oct7

McCormick covers and recommends healthcare industry stocks

12:36

Schedules & Filings

Schedules

Filings

Nov12

Earning Release(EST)

FY2025 Q3 Earning Release (USD) Net Income -5.284 M, EPS -0.1509

Aug12

Earning Release(EST)

FY2025 Q2 Earning Release (USD) Net Income -5.809 M, EPS -0.1914

May14

Earning Release(EST)

FY2025 Q1 Earning Release (USD) Net Income -4.53 M, EPS -0.1579

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change